Miyoshi H, Ohshiba S, Asada S, Hirata I, Uchida K
Second Department of Internal Medicine, Osaka Medical College, Japan.
Am J Gastroenterol. 1992 Jan;87(1):67-73.
Immunological determination of fecal hemoglobin and transferrin levels was performed in inpatients on an unrestricted diet, including patients with colon cancer or polyps and a control group. When hemoglobin levels of 5.1 micrograms/g feces and transferrin levels of 0.4 microgram/g feces were designated as positive, 48 of the 60 fecal specimens from colon cancer patients were positive. This result was significantly superior to that for another fecal occult blood immunological test (FECA-EIA) (p less than 0.005), and similar to the results of two chemical tests (guaiac and Hemoccult). Twenty-eight of the 78 fecal specimens from patients with colonic polyps were positive, again a result superior to the FECA-EIA (p less than 0.005) and similar to the chemical tests. Three of the 99 control fecal specimens were positive, which was a similar result to that obtained with the FECA-EIA and significantly superior to the chemical tests (both p less than 0.005). Thus, combined detection of fecal hemoglobin and transferrin levels can be used as a fecal occult blood test in patients without dietary restriction.
对饮食不受限制的住院患者进行了粪便血红蛋白和转铁蛋白水平的免疫学检测,其中包括结肠癌或息肉患者以及一个对照组。当粪便血红蛋白水平为5.1微克/克粪便且转铁蛋白水平为0.4微克/克粪便被定为阳性时,60份结肠癌患者的粪便标本中有48份呈阳性。这一结果明显优于另一种粪便潜血免疫学检测(FECA-EIA)(p<0.005),且与两种化学检测(愈创木脂法和隐血试验)的结果相似。78份结肠息肉患者的粪便标本中有28份呈阳性,同样优于FECA-EIA(p<0.005)且与化学检测结果相似。99份对照粪便标本中有3份呈阳性,这与FECA-EIA的结果相似,且明显优于化学检测(两者p均<0.005)。因此,粪便血红蛋白和转铁蛋白水平的联合检测可作为饮食不受限制患者的粪便潜血检测方法。